Learn more in our training program.
Join our membership network.
Attend our events and collaborate.
Add your voice to our policy matters.
Get involved in our genetic registry.
Donate to our cause.
The Latino Cancer Institute (TLCI) is a nationwide community and research network dedicated to solving the issues and burden of Latino cancer.
Cancer remains one of the leading causes of death among Hispanics/Latinos in the U.S., accounting for approximately 17% of deaths. At the same time, federal support for health equity and cancer disparities research is facing unprecedented cuts—making community-driven leadership more critical than ever.
Cancer affects Latino men and women differently, requiring targeted approaches. Among Latinas, breast cancer remains the most commonly diagnosed cancer and the leading cause of cancer death, while cervical cancer continues to pose a serious and largely preventable threat.
For Latino men, the challenges are equally urgent. Lung cancer remains the leading cause of cancer death, and Latino men are more likely to be diagnosed with prostate, colorectal, liver, and testicular cancers—often at later stages.
Our mission. The Latino Cancer Institute works to reduce the burden of cancer in Latino communities by convening expertise, amplifying community-informed research, and advocating for equitable cancer care. As public funding becomes more uncertain, philanthropic support helps ensure Latino communities are not left out of cancer research, policy discussions, or solutions. Learn more about our work.
For over 20 years, Founder Ysabel Duron has played a vital role in bringing together those dedicated to making a difference in the Latino cancer landscape. From cancer community workers and caregivers to international medical researchers and policymakers, Ysabel has forged important alliances in a field crowded with many competing interests and agendas.
It takes a savvy insider who has traveled this terrain far and wide to help the Latino cancer community at-large continue changing the landscape. TLCI offers the definitive road map.
There are currently no upcoming events.
The Latino Cancer Institute acts as a network for agencies, linking members to share knowledge and best practices. Connecting colleagues, peers and institutions is critical to The Institute’s ongoing mission to amplify and disseminate outstanding work in the cancer arena, and to support one another.
The Latino Cancer Institute provides opportunities to network, learn and collaborate with stakeholders in the cancer landscape including Latino cancer researchers.
The Latino Cancer Institute convenes leading experts, advocates, and community voices to examine critical cancer issues affecting Latino communities and to surface actionable insights. Recordings from TLCI’s recent Forums are now available—free to watch—covering cancer risks, disparities, and lived experiences across Latino women, men, children, and families. Watch Forum videos.
The Latino Cancer Institute leverages our united voice at the national table to advance Latino cancer concerns including education, services, funding, and research. Our aim is to be heard, understood and included in any proposed policy.
As a nonprofit organization, we rely on philanthropy and grants in our mission to support other agencies. Your funding allows us to continue the development of new programs and tools we can share with those making a difference in the lives of Latino cancer patients, survivors, and their caregivers.
Scientists have discovered that vitamin C may help prevent potentially cancer-causing chemicals from forming in the stomach after eating foods containing nitrates and nitrites. A new mathematical model suggests that taking vitamin C after meals could reduce these harmful reactions, offering a possible new strategy for lowering cancer risk.
Scientists have uncovered a surprising genetic connection to spinal degeneration and found that an existing osteoporosis drug can prevent damaging mineral buildup in zebrafish spines. The discovery could pave the way for new treatments that slow or prevent a major cause of chronic back pain.
A surprising discovery from Rockefeller University suggests that a common amino acid could play a powerful role in protecting against cancer and viral infections. Scientists found that low arginine levels interfere with the immune system's ability to recognize dangerous cells, while increasing arginine intake reduced colon cancer tumors and improved viral infection outcomes in mice. Even more remarkably, giving mice arginine after they contracted influenza helped them recover.
Yale researchers have discovered that certain prescription drugs, healthy diets, and exercise can measurably slow biological aging, while popular anti-aging supplements appear largely ineffective. Their analysis of 51 studies could transform how scientists evaluate anti-aging treatments, although whether these biological changes actually extend life remains uncertain.
A new study reveals that viral infections may leave behind hidden damage to the immune system long after symptoms disappear. Researchers found that mice recovering from an acute infection experienced lasting changes to their spleens and weakened immune responses, potentially leaving them more vulnerable to future threats. Surprisingly, prior vaccination completely prevented these harmful changes in the mouse model.
A major study of nearly 1,900 older adults suggests that stopping statins after age 70 may be relatively safe in the short term for people who have never experienced a heart attack or stroke. However, a higher rate of serious cardiovascular events or death during longer follow-up raises questions about the risks of discontinuing these widely prescribed medications.
